| CPC A61K 31/05 (2013.01) [A61P 21/00 (2018.01)] | 4 Claims |
|
1. An application of tyrosol and/or tyrosol derivatives as physiological effect enhancers for creatine and/or creatine derivatives; wherein the one or more enhanced physiological effects selected from the group consisting of improving muscle endurance, reducing decline in muscle strength, enhancing utilization of creatine by muscles; tyrosyl stimulating the endurance-enhancing effects of creatine, reducing the decline of endurance levels; accelerating resynthesis of phosphocreatine, increasing levels of phosphocreatine; improving resistance performance and endurance exercise performance; the muscle endurance does not significantly decline, after continuous high-intensity exercise: wherein the tyrosol and/or the tyrosyl derivatives include salts, esters, acids, ketones, polymers, co-crystals, chelates, complexes, glycosides, hydrates, and substances formed by non-chemical bonding with other substances; and/or creatine and/or creatine derivatives include salts, esters, ketones, hydrates, polymers, co-crystals, chelates, complexes, glycosides, and substances formed by non-chemical bonding with other substances.
|